Evidence map›Paper›PMID 40381193›Full record

ArticleCell reports2025

An integrated proteomics approach identifies phosphorylation sites on viral and host proteins that regulate West Nile virus infection.

Zachary Walter, Minghua Li, Melissa Molho, Lauren Berish, Andrew Isopi, Mary O'Mara, Mark Dittmar, Chike Nwaezeapu, Alicia Richards, Martin McCullagh and 4 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zachary WalterDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Minghua LiDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Melissa MolhoDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Lauren BerishDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Andrew IsopiDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Mary O'MaraDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Mark DittmarDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Chike NwaezeapuDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Alicia RichardsDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94143, USA.
Martin McCullaghDepartment of Chemistry, Oklahoma State University, Stillwater, OK 74078, USA.
Nevan J KroganDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA 94143, USA; The J. David Gladstone Institutes, San Francisco, CA 94158, USA.
Sara CherryDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: cherrys@pennmedicine.upenn.edu.
Jeffrey R JohnsonDepartment of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: jeffrey.johnson@mssm.edu.
Holly RamageDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: holly.ramage@jefferson.edu.

Funding

Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunityR01AI124690 · NIAID · ROCKEFELLER UNIVERSITY · PI Charles M Rice · 2016 to 2026
$8.3M
The role of pattern recognition and autophagy in innate anti-bunyaviral immunityR01AI150246 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2019 to 2023
$3.5M
Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2R01AI170596 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jeffrey R Johnson · 2023 to 2026
$3.4M
Defining the functional interface between the ER and flavivirusesR01AI140539 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA, DIAMOND, MICHAEL S · 2018 to 2022
$3.0M
Defining the Role of West Nile Virus-Host Protein Interactions in Evading Antiviral ImmunityR01AI143850 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI RAMAGE, HOLLY · 2019 to 2023
$2.2M
Training Grant in Cellular, Biochemical and Molecular SciencesT32GM144302 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI DIANE E MERRY, PHILIP B WEDEGAERTNER · 2022 to 2026
$2.0M
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.R01AI152362 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2020 to 2024
$2.0M
CRISPR-Cas9 base editing approaches to discover ubiquitination events promoting flavivirus infectionR21AI187731 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jeffrey R Johnson · 2025 to 2026
$457k
NIAID NIH HHS R01 AI124690NIAID NIH HHS R01 AI140539NIAID NIH HHS R01 AI143850NIAID NIH HHS R01 AI150246NIAID NIH HHS R01 AI152362NIAID NIH HHS R01 AI170596NIAID NIH HHS R21 AI187731NIGMS NIH HHS T32 GM144302
6 · The paper itself

Abstract

Upon infection, viruses alter the proteome, creating a hospitable environment for infection. Cells respond to limit viral replication, including through protein regulation by post-translational modifications. We use mass spectrometry to define proteome alterations during West Nile virus (WNV) infection. Our studies identify upregulation of HERPUD1, which restricts WNV replication through a mechanism independent of its role in endoplasmic reticulum (ER)-associated degradation (ERAD). We also identify modifications on viral proteins, including a WNV NS3 phosphorylation site that impacts viral replication. Finally, we reveal activation of two host kinases with antiviral activity. We identify phosphorylation at S108 of AMPKβ1, a non-catalytic subunit that regulates activity of the AMPK complex. We also show activation of PAK2 by phosphorylation at S141, which restricts translation of the viral genome. This work contributes to our understanding of the interplay between host and virus while providing a resource to define the changes to the proteome that regulate viral infection.

Indexed as

ProteomicsViral ProteinsWest Nile FeverWest Nile virusAnimalsHEK293 CellsHost-Pathogen InteractionsHumansMembrane ProteinsPhosphorylationProtein Processing, Post-TranslationalProteomeViral Nonstructural ProteinsVirus ReplicationMembrane ProteinsProteomeViral Nonstructural ProteinsViral ProteinsCP: Microbiologyinnate immunityOrthoflavivirusesphosphorylationpost-translational modificationsviral helicaseviral translationvirus-host interactionsWest Nile virus

Identifiers

PMID40381193
PMCPMC12180539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.